Equol is Neuroprotective During Focal Cerebral Ischemia and Reperfusion that Involves p-Src and gp91phox
The DOI matches its Crossref record.
Abstract
Both of gp91(phox) (an isoform of nicotinamide adenine dinucleotide phosphate reduced oxidases) and Src (a nonreceptor protein tyrosine kinase) are abundantly expressed in the brain and play a prominent role in mediating ischemic alteration in neurons. The inhibitory strategy of them is believed to be the promising treatment of stroke. The present study was designed to investigate the effect of equol (0.625-2.5 mg·kg(-1), i.g. for 3 days), a predominant active metabolite of daidzein, on neuroprotection against cerebral ischemia/reperfusion injury in rats and the underlying mechanisms. We found that equol decreased the mortality, neurological deficit, brain histological damage, infarct volume, serum lactate dehydrogenase activity and malondialdehyde content in a dose-dependent manner in rats with 2-h middle cerebral artery occlusion, followed by 22-h reperfusion. Western blot analysis revealed that protein levels of gp91(phox) and phosphorylated Src-Tyr416 (p-Src) in ischemic cerebral cortex were increased in rats treated with vehicle, which was reversed in animals treated with equol. In rat pheochromocytoma cell line (PC12) with hypoxia/reoxygenation injury, silencing of gp91(phox) with specific siRNA did not affect the increase of p-Src level by hypoxia/reoxygenation injury and the inhibition of p-Src level by equol, while silencing of Src suppressed the upregulation of gp91(phox) by hypoxia/reoxygenation injury and enhanced the inhibitory effect of equol on gp91(phox) expression. These results demonstrate that equol confers a neuroprotection in rats via inhibiting the activation of Src and upregulation of gp91(phox) induced by focal cerebral ischemia/reperfusion, and Src may play a partial role in regulating gp91(phox) expression of neurons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Gut Microbiota: The Brain Peacekeeper
Mu, C., Yang, Y., & Zhu, W. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00345 · Cited by 188
“Equol administration exerts neuroprotection against cerebral ischemia/reperfusion injury in rats by decreasing brain histological damage and inhibiting phospho-Src (Yu et al., 2014).”
BackgroundA prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis
Di Gioia, D., Bozzi Cionci, N., Baffoni, L., Amoruso, A., Pane, M., Mogna, L., Gaggìa, F., Lucenti, M. A., Bersano, E., Cantello, R., et al. (2020) · BMC Medicine · doi:10.1186/s12916-020-01607-9 · Cited by 151
“metabolism of dietary daidzein [69], known to have a neuroprotective activity [70].”
BackgroundSubedi, L., Ji, E., Shin, D., Jin, J., Yeo, J., & Kim, S. (2017) · Nutrients · doi:10.3390/nu9030207 · Cited by 133
Beilharz, J. E., Kaakoush, N. O., Maniam, J., & Morris, M. J. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.07.151 · Cited by 93
Metadata
- Authors
- Yu, W., Wang, Y., Zhou, D.-X., Zhao, L.-M., Li, G.-R., & Deng, X.-L.
- Venue
- Current Neurovascular Research
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2014-10-16
- Volume
- 11
- Issue
- 4
- Pages
- 367-377
- ISSN
- 1567-2026 (ISSN-L)
- OpenAlex
- W2160846300
- Cited by
- 24
- References
- 0
- FWCI
- 0.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Equol is Neuroprotective During Focal Cerebral Ischemia and Reperfusion that Involves p-Src and gp91phox. https://app.cochat.ai/papers/10.2174/1567202611666140908094517
- The paper
- Yu, W., Wang, Y., Zhou, D.-X., Zhao, L.-M., Li, G.-R., & Deng, X.-L. (2014). Equol is Neuroprotective During Focal Cerebral Ischemia and Reperfusion that Involves p-Src and gp91phox. Current Neurovascular Research. https://doi.org/10.2174/1567202611666140908094517
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.